30.09.2018 Views

Indian Newslink October 1 2018 Digital Edition

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

OCTOBER 1, <strong>2018</strong><br />

Businesslink<br />

15<br />

Continued from Page 14<br />

An appetite to regulate: On the<br />

surface, there appears to be little<br />

appetite for any full-scale banking<br />

inquiry or further regulation<br />

of the banking sector.<br />

No inquiry needed<br />

In April, Reserve Bank Governor<br />

Adrian Orr told Q&A there<br />

was no need for an inquiry in<br />

New Zealand, saying the problem<br />

was cultural.<br />

But later, the Reserve Bank<br />

joined with the Financial Markets<br />

Authority on a review into the<br />

culture of the banking sector.<br />

The banks were asked to “prove”<br />

that their culture was better than<br />

their Australian parents.<br />

Select Committee Hearing<br />

But this did not go far enough<br />

for Labour MP Michael Wood,<br />

Chair of the Finance and<br />

Expenditure Committee, who<br />

told interest.co.nz that he could<br />

summon Chief Executives of<br />

banks to give evidence before the<br />

committee if he felt it necessary.<br />

But Wood was forced to do a<br />

U-turn on that statement after<br />

discovering that the banks were<br />

under a confidentiality order<br />

with the FMA concerning evidence<br />

they were giving as a part<br />

of that inquiry. He was forced to<br />

back-pedal after Orr raised the<br />

matter with Finance Minister<br />

Grant Robertson.<br />

ACT leader David Seymour,<br />

who sits on the Committee said<br />

the submission from the Banking<br />

Ombudsman showed regulation<br />

was working well.<br />

“There is not a problem with<br />

banking regulation in New<br />

Zealand. You could have further<br />

regulation, but that comes at a<br />

cost,” he said.<br />

Banks will be banks<br />

Seymour said that customers<br />

should be aware that banks<br />

would try to sell them products.<br />

“Anyone that goes to a bank<br />

and does not believe that the<br />

bank is trying to sell you stuff and<br />

make money probably should<br />

not be going to a bank in the first<br />

place,” he said.<br />

“Maybe we should ban McDonald’s<br />

for asking if you’d like fries<br />

with that?” he said.<br />

National leader Simon Bridges<br />

also said he would wait for the<br />

outcome of the FMA and Reserve<br />

Bank probe.<br />

“Let’s see where they get to, if<br />

they don’t I certainly wouldn’t<br />

be in a rush to having our own<br />

Aussie-style inquiry,” he said.<br />

Finance Minister Grant Robertson<br />

has said that he is watching<br />

the FMA and Reserve Bank probe<br />

closely and would not make a<br />

decision on whether to appoint<br />

an Australian-style inquiry unless<br />

the probe turned up evidence for<br />

one.<br />

Thomas Coughlan is a<br />

Newsroom reporter based<br />

in Wellington who writes on<br />

policy and economics. <strong>Indian</strong><br />

<strong>Newslink</strong> has published the<br />

above story and Picture that<br />

appeared in Newsroom on<br />

September 20, <strong>2018</strong> under a<br />

Special Agreement.<br />

IRD says Oxfam report<br />

on pharmas misleading<br />

The Oxfam report<br />

claiming pharmaceutical<br />

companies<br />

in New Zealand are<br />

underpaying tax by some $21<br />

million completely misrepresents<br />

the situation here says<br />

Inland Revenue Department<br />

(IRD) international Strategy<br />

Manager, John Nash.<br />

“Obviously we cannot comment<br />

on specific taxpayers<br />

but taking a global profitability<br />

figure and applying<br />

it across the board, as this<br />

report does, cannot illustrate<br />

what’s really happening in<br />

this country,” he said.<br />

Global versus local<br />

“The report tries to apply<br />

a globally derived profit<br />

margin figure of 15-16% to<br />

New Zealand drug company<br />

revenue of $519 million and<br />

concludes that they have<br />

underpaid tax by $21 million.<br />

This is clearly incorrect<br />

given the type of operations<br />

that multinational pharmaceutical<br />

companies actually<br />

undertake in New Zealand,”<br />

Mr Nash said.<br />

He said that the Oxfam<br />

methodology applied a global<br />

average profit margin to the<br />

New Zealand operations of<br />

pharmaceutical companies<br />

while at the same time<br />

acknowledging that profit<br />

margins were not uniform all<br />

over the world.<br />

No IP issues in New<br />

Zealand<br />

“The main driver of profitability<br />

in this industry is the<br />

creation and development of<br />

intellectual property but such<br />

activities are not generally<br />

carried out in New Zealand.<br />

It is important to examine<br />

what multinationals actually<br />

do in a specific country such<br />

as New Zealand and how<br />

value is added, before<br />

arriving at a conclusion that<br />

insufficient taxation has<br />

been paid. The New Zealand<br />

operations of pharmaceutical<br />

companies are almost entirely<br />

lower margin activities like<br />

distribution,” Mr Nash said.<br />

He described Pharmac<br />

as an ‘active regulator’<br />

impacting the profitability of<br />

pharmaceutical companies<br />

in New Zealand.<br />

Mr Nash said that Inland<br />

Revenue is working closely<br />

with multinationals of all<br />

kinds operating in New Zealand<br />

to ensure compliance<br />

as well as working with the<br />

OECD in the collective effort<br />

to improve compliance by<br />

multinationals worldwide

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!